We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.9%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$57.6B
AUM Growth
+$7.69B
(+15%)
Cap. Flow
+$3.7B
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
1,054
New
202
Increased
277
Reduced
473
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$3.4B |
| 2 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$885M |
| 3 |
Tesla
TSLA
|
+$252M |
| 4 |
Amazon
AMZN
|
+$156M |
| 5 |
CLVT.PRA
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$379M |
| 2 |
Sherwin-Williams
SHW
|
+$161M |
| 3 |
NVIDIA
NVDA
|
+$154M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$116M |
| 5 |
Boeing
BA
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Consumer Discretionary | 15.59% |
| 3 | Communication Services | 15.36% |
| 4 | Healthcare | 13.38% |
| 5 | Financials | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Neurocrine Biosciences
NBIX
$16.8B
| $16.5M | 0.03% |
+163,003
| New | +$17M |
|
|
LSXMK
252
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $16.2M | 0.03% |
748,039
-69,236
| -8% | -$1.82M |
|
|
PXD
253
DELISTED
Pioneer Natural Resource Co.
PXD
| $16.1M | 0.03% |
78,828
+60,187
| +323% | +$12.9M |
|
254
Avantor
AVTR
$9.29B
| $15.8M | 0.03% |
748,164
+42,411
| +6% | +$966K |
|
255
Axos Financial
AX
$5.63B
| $15.8M | 0.03% |
428,222
-159,399
| -27% | -$6.88M |
|
256
Glacier Bancorp
GBCI
$6.35B
| $15.7M | 0.03% |
373,757
-186,967
| -33% | -$8.55M |
|
257
Wintrust Financial
WTFC
$10.7B
| $15.7M | 0.03% |
215,079
-4,945
| -2% | -$423K |
|
258
JB Hunt Transport Services
JBHT
$25B
| $15.6M | 0.03% |
89,091
-7,406
| -8% | -$1.35M |
|
259
Korn Ferry
KFY
$4.25B
| $15.6M | 0.03% |
301,768
-11,795
| -4% | -$637K |
|
260
Federal Agricultural Mortgage
AGM
$2.54B
| $15.4M | 0.03% |
115,704
-1,217
| -1% | -$160K |
|
261
Pool Corp
POOL
$7.27B
| $15.4M | 0.03% |
44,848
-26,070
| -37% | -$9.25M |
|
262
MDU Resources
MDU
$4.29B
| $14.7M | 0.03% |
1,264,036
-80,551
| -6% | -$936K |
|
263
Cabot Corp
CBT
$4.46B
| $14.6M | 0.03% |
190,948
-2,161
| -1% | -$162K |
|
264
Coherent
COHR
$63.6B
| $14.6M | 0.03% |
+382,405
| New | +$15.6M |
|
265
Crocs
CROX
$6.63B
| $14.5M | 0.03% |
114,758
-50,208
| -30% | -$6.07M |
|
266
Jazz Pharmaceuticals
JAZZ
$16.7B
| $14.5M | 0.03% |
98,822
-24,322
| -20% | -$3.6M |
|
267
Tractor Supply
TSCO
$18B
| $14.3M | 0.02% |
304,875
-23,375
| -7% | -$1.06M |
|
268
Antero Resources
AR
$11.4B
| $14.3M | 0.02% |
619,263
-151,504
| -20% | -$3.99M |
|
269
ITT
ITT
$18.9B
| $14.2M | 0.02% |
164,963
-12,421
| -7% | -$1.09M |
|
270
APi Group
APG
$18.3B
| $13.9M | 0.02% |
930,429
+97,507
| +12% | +$1.4M |
|
271
Travel + Leisure Co
TNL
$4.5B
| $13.8M | 0.02% |
353,103
-25,529
| -7% | -$1.03M |
|
272
STAG Industrial
STAG
$7.09B
| $13.7M | 0.02% |
406,098
-3,720
| -0.9% | -$127K |
|
|
HOLX
273
DELISTED
Hologic
HOLX
| $13.7M | 0.02% |
169,308
-49,894
| -23% | -$4.02M |
|
274
Vistra
VST
$48.2B
| $13.6M | 0.02% |
568,219
-53,885
| -9% | -$1.25M |
|
275
Eagle Materials
EXP
$6.47B
| $13.6M | 0.02% |
92,613
-7,569
| -8% | -$1.07M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2023 Portfolio in Review
As of Q1 2023, Loomis, Sayles & Company held 1,054 positions worth $57.6B, up 15% from $49.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Loomis, Sayles & Company deployed $3.7B of net new capital in Q1 2023, opening 202 new positions and adding to 277 existing holdings. Its largest new stake was Bank of America Series L: 2,835,020 shares worth $81.1M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Novartis, an estimated $379M trimmed.
- Loomis, Sayles & Company's largest Q1 2023 buy was Bank of America Series L: 2,835,020 shares worth $81.1M.
- Loomis, Sayles & Company added most to Tesla in Q1 2023, an estimated $252M increase.
- Loomis, Sayles & Company's biggest Q1 2023 reduction was Novartis, cutting an estimated $379M.
- Loomis, Sayles & Company fully exited Globus Medical in Q1 2023, selling an estimated $38M.
- Loomis, Sayles & Company's ten largest holdings make up 40% of its $57.6B portfolio in Q1 2023.
- Loomis, Sayles & Company opened 202 new positions and closed 81 in Q1 2023.
- Loomis, Sayles & Company's portfolio value rose 15% quarter-over-quarter to $57.6B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2023, filed 11 May 2023.